BerandaHESTERBIO • NSE
add
Hester Biosciences Ltd
Tutup sebelumnya
₹1.861,00
Rentang hari
₹1.849,80 - ₹2.070,00
Rentang tahun
₹1.242,95 - ₹3.379,00
Kapitalisasi pasar
16,56Â M INR
Volume Rata-Rata
2,50Â rb
Rasio P/E
57,10
Hasil dividen
0,36%
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Pendapatan | 749,75Â jt | -5,58% |
Biaya operasional | 461,78Â jt | 10,78% |
Laba bersih | 12,91Â jt | -73,92% |
Margin laba bersih | 1,72 | -72,39% |
Penghasilan per saham | — | — |
EBITDA | 122,56Â jt | -25,96% |
Tarif pajak efektif | 58,85% | — |
Neraca
Total aset
Total liabilitas
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 72,19Â jt | -52,83% |
Total aset | 6,53Â M | -1,35% |
Total liabilitas | 3,27Â M | -9,11% |
Total ekuitas | 3,27 M | — |
Saham yang beredar | 7,09 jt | — |
Harga terhadap nilai buku | 4,20 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 3,67% | — |
Arus Kas
Perubahan kas bersih
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Laba bersih | 12,91Â jt | -73,92% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
Didirikan
1983
Situs
Karyawan
562